IRIS
ALTIERI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.273
NA - Nord America 1.268
SA - Sud America 520
EU - Europa 398
AF - Africa 157
Continente sconosciuto - Info sul continente non disponibili 119
OC - Oceania 2
Totale 4.737
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.200
SG - Singapore 970
VN - Vietnam 402
BR - Brasile 378
HK - Hong Kong 343
CN - Cina 203
BD - Bangladesh 157
IT - Italia 125
ZA - Sudafrica 115
NL - Olanda 101
FR - Francia 92
AR - Argentina 60
IN - India 42
MX - Messico 26
CA - Canada 23
IQ - Iraq 23
CO - Colombia 17
EC - Ecuador 17
JP - Giappone 14
TR - Turchia 14
DE - Germania 13
ID - Indonesia 13
MY - Malesia 13
GB - Regno Unito 12
MA - Marocco 12
RU - Federazione Russa 11
VE - Venezuela 11
PE - Perù 10
PK - Pakistan 10
PY - Paraguay 9
UA - Ucraina 9
CL - Cile 8
SA - Arabia Saudita 8
EG - Egitto 7
ES - Italia 7
PL - Polonia 7
TH - Thailandia 7
AZ - Azerbaigian 6
PH - Filippine 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
KE - Kenya 5
UY - Uruguay 5
RS - Serbia 4
TN - Tunisia 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
NI - Nicaragua 3
AL - Albania 2
AU - Australia 2
EE - Estonia 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KR - Corea 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
MU - Mauritius 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BZ - Belize 1
CG - Congo 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
MR - Mauritania 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
SE - Svezia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 4.619
Salva come PNG Salva come JPEG
Città #
San Jose 415
Singapore 359
Hong Kong 330
Ashburn 155
Ho Chi Minh City 139
Council Bluffs 121
Johannesburg 107
Lauterbourg 87
Hanoi 79
Boardman 54
Dallas 47
Los Angeles 45
Beijing 29
São Paulo 29
New York 25
Milan 22
Buffalo 18
Rio de Janeiro 16
Columbus 15
Da Nang 15
Hefei 14
Santa Clara 14
Haiphong 13
Parma 12
Biên Hòa 10
Des Moines 10
Mexico City 10
Rome 9
Tokyo 9
Brasília 8
Brooklyn 8
Can Tho 8
Chicago 8
Orem 8
Asunción 7
Baghdad 7
Belo Horizonte 7
Curitiba 7
Kuala Lumpur 7
Montreal 7
San Francisco 7
Casablanca 6
Chennai 6
Guayaquil 6
Lima 6
Salvador 6
Warsaw 6
Würzburg 6
Buenos Aires 5
Denver 5
La Paz 5
Medellín 5
Phoenix 5
Quito 5
Shanghai 5
Tashkent 5
Thái Bình 5
Toronto 5
Wuhan 5
Zhengzhou 5
Baku 4
Bogotá 4
Cairo 4
Cape Town 4
Changsha 4
Erbil 4
Fortaleza 4
Frankfurt am Main 4
Istanbul 4
Joinville 4
Karachi 4
Montevideo 4
Nairobi 4
New Delhi 4
Piracicaba 4
Recife 4
Santiago 4
Shijiazhuang 4
São José 4
São José dos Campos 4
Tianjin 4
Verona 4
Bangkok 3
Basra 3
Belgrade 3
Bishkek 3
Bắc Giang 3
Campinas 3
Canoas 3
Catania 3
Charlotte 3
Conselheiro Lafaiete 3
Criciúma 3
Delhi 3
Dhaka 3
Elk Grove Village 3
Guarulhos 3
Jakarta 3
Jeddah 3
Lahore 3
Totale 2.541
Salva come PNG Salva come JPEG
Nome #
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 103
Recovery of hypopituitarism in macroprolactinomas: a comparison of medical vs. surgical treatment. Results from a European multicenter study 91
Machine learning-based survival prediction tool for adrenocortical carcinoma 89
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management 81
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 77
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma 72
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 72
4. Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 68
Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept 66
"Expression and prognostic relevance of PD-1, PD-L1 and CTLA-4 immune checkpoints in adrenocortical carcinoma" 65
SOX2+ sustentacular cells are stem cells of the postnatal adrenal medulla 64
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study 63
An Italian Survey of compliance with major guidelines for L-thyroxine of primary hypothyroidism 61
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies 60
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 60
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors 60
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 60
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 59
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy 58
Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report 58
Single-nucleus and spatial transcriptome reveal adrenal homeostasis in normal and tumoral adrenal gland 56
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15: Impact on poor prognosis and impaired responsiveness to immunotherapy 56
Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus 55
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma 55
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 55
Adrenal disorders: Is there Any role for vitamin D? 54
Medical therapy of endogenous Cushing's syndrome with steroidogenesis inhibitors: treatment rationale, available drugs, and therapeutic effects 54
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma 52
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study 51
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 51
The interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma 51
Chronotype and cardio metabolic health in obesity: does nutrition matter? 51
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 51
Focus on vitamin D and the adrenal gland 50
Clinical and penile Doppler outcomes using a modified, tourniquet free, Nesbit plication for severe Peyronie's disease 50
Circulating microRNA Expression in Cushing's Syndrome 50
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 49
Adrenocortical tumors and insulin resistance. What is the first step? 48
Management of Patients with Glucocorticoid-Related Diseases and COVID-19 47
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 47
Next-generation therapies for adrenocortical carcinoma 47
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 46
Vitamin D and chronic diseases: the current state of the art 46
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors 45
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution 45
The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors 45
Nutrition and neuroendocrine tumors: an update of the literature 44
Low bone mineral density in a growth hormone deficient (GHD) adolescent 44
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 43
Sex differences in carcinoid syndrome: A gap to be closed 43
FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma 42
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 42
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection 42
Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma 42
Integrative genomic analysis reveals a conserved role for prolactin signalling in the regulation of adrenal function 42
Shedding new light on female fertility: The role of vitamin D 41
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma 41
Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature 40
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas 40
Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of Diabetes Mellitus and Pancreatic Cancer 39
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study 39
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma 39
Erythropoiesis in Cushing syndrome: sex-related and subtype-specific differences. Results from a monocentric study 39
Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome 39
Gemcitabine-Based Chemotherapy In Adrenocortical Carcinoma: A Multicentric Study On Efficacy and Predictive Factors 39
Does vitamin D play a role in Autoimmune Endocrine Disorders? A proof of concept 38
Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication 37
Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm 37
Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study 37
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis 36
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 36
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness 36
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma 35
Current evidence on vitamin D deficiency and kidney transplant: What's new? 35
Vitamin D and Bone Metabolism in Adult Patients with Neurofibromatosis Type 1 35
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors 35
Outcome of Immunotherapy in Adrenocortical Carcinoma - A retrospective cohort study 35
Metyrapone Versus Osilodrostat in the Short-Term Therapy of Endogenous Cushing's Syndrome: Results From a Single Center Cohort Study 34
Effects of germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study 34
Efficacy and safety of radiation therapy in advanced adrenocortical carcinoma 34
Editorial: Endocrine malignancies: from pathophysiology to current clinical and surgical therapeutic approaches 33
Morbidity in Patients with Chronic Adrenal Insufficiency - Cardiovascular Risk Factors and Hospitalization Rate Compared to Population Based Controls 33
Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism 33
Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma 32
Novel AIP mutation in exon 6 causing acromegaly in a German family 31
RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights 31
Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study 31
Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers 31
Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma 31
Consecutive adrenal Cushing´s syndrome and Cushing´s disease in a patient with somatic CTNNB1, USP8, and NR3C1 mutations 30
Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety 29
Targeted gene expression profile reveals CDK4 as therapeutic target for selected patients with adrenocortical carcinoma 29
The Importance of Being a ‘Lark' in Post-Menopausal Women with Obesity: A Ploy to Prevent Type 2 Diabetes Mellitus? 27
Identifying New Potential Biomarkers in Adrenocortical Tumors Based on mRNA Expression Data Using Machine Learning 27
Current Evidence on Local Therapies in Advanced Adrenocortical Carcinoma 27
Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study 27
Bone metabolism, bone mass and structural integrity profile in professional male football players 27
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation 26
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma 26
Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues? 25
Totale 4.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025875 0 0 0 0 0 0 0 0 275 206 50 344
2025/20263.622 178 439 479 262 486 149 427 90 418 277 209 208
2026/2027240 149 91 0 0 0 0 0 0 0 0 0 0
Totale 4.737